Trial reportEuropean journal of nuclear medicine and molecular imaging2021
Can the BMI-based dose regimen be used to reduce injection activity and to obtain a constant image quality in oncological patients by
Trial report in European journal of nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 38 citations in OpenAlex.
- Smart scanning for two: [EJNMMI physics · 2026Article
- A low-dose protocol in pediatricAnnals of nuclear medicine · 2025Article
- EnhancingCancer imaging : the official publication of the International Cancer Imaging Society · 2025Article
- Low dose optimization for total-body 2-[European radiology · 2025Article
- Expert consensus on workflow of PET/CT with long axial field-of-view.European journal of nuclear medicine and molecular imaging · 2025Review
- The predictive value of total body PET/CT in high PD-L1 expression and immunotherapy in advanced non-small cell lung cancer patients.Frontiers in oncology · 2025Article
- Fully automated computational measurement of noise in positron emission tomography.European radiology · 2024Article
- Automated F18-FDG PET/CT image quality assessment using deep neural networks on a latest 6-ring digital detector system.Scientific reports · 2023Article
- Impact of Region-of-Interest Delineation on Stability and Reproducibility of Liver SNR Measurements inWorld journal of nuclear medicine · 2023Article
- A personal acquisition time regimen ofCancer imaging : the official publication of the International Cancer Imaging Society · 2022Article
- Deep progressive learning achieves whole-body low-doseEJNMMI physics · 2022Article
- The feasibility of ultralow-activityAnnals of nuclear medicine · 2022Article
- RelatingPhysics in medicine and biology · 2022Article
- Exploration of the total-body PET/CT reconstruction protocol with ultra-lowEJNMMI physics · 2022Article
- The predictive value of total-body PET/CT in non-small cell lung cancer for the PD-L1 high expression.Frontiers in oncology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 6 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePET image quality is influenced by the patient size according to the current guideline. The study aimed to propose an optimized dose regimen to yield a constant image quality independent of patient habitus to meet the clinical needs.
methodsA first patient cohort of 78 consecutive oncological patients (59.7 ± 13.7 years) who underwent a total-body PET/CT scan were retrospectively enrolled to develop the regimen. The patients were randomly distributed in four body mass index (BMI) groups according to the World Health Organization (WHO) criteria. The liver SNR (signal-to-noise ratio, SNR
resultsThe linear fit showed SNR
conclusionThe study proposed a quadratic relation between the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.